Peptides catalog
A structured reference covering 105 research peptides and related compounds, organized by compound with reference codes and forms. Each entry links to an educational overview plus dedicated pages on benefits, side effects, dosing concepts, and research evidence. Use the search and family filters below to find a specific compound or browse a class.
New to some of the terms? Browse the glossary.
105 Results
5-amino-1mq
NNMT inhibitor (small molecule)
PreclinicalACE-031
Myostatin/activin inhibitor (ACVR2B trap)
Clinical-stageAdipotide (FTPP)
Experimental pro-apoptotic peptide
PreclinicalAHK-Cu
Copper peptide
Minimal evidenceAICAR
AMPK activator
Clinical-stageAlprostadil
Prostaglandin E1
Approved medicineAOD-9604
Growth hormone fragment
Clinical-stageAra-290
Erythropoietin-derived peptide
Clinical-stageB7-33
Relaxin (H2) analog
PreclinicalBAC water
Diluent
Botulinum toxin
Neurotoxin
Approved medicineBPC-157
Synthetic peptide fragment
PreclinicalBPC-157 + GHK-Cu + KPV
Peptide blend
Minimal evidenceBPC-157 + GHK-CU + TB500
Peptide blend
Minimal evidenceBPC-157 + GHK-CU + TB500 + KPV
Peptide blend
Minimal evidenceBPC-157 + TB500
Peptide blend
Minimal evidenceBronchogen
Peptide bioregulator (Khavinson)
Minimal evidenceCagrilintide
Long-acting amylin analog
Clinical-stageHalf-life ~7 days
Cagrilintide + Semaglutide
Amylin analog + GLP-1 receptor agonist combination
Clinical-stageCardiogen
Peptide bioregulator (Khavinson)
Minimal evidenceCartalax
Peptide bioregulator (Khavinson)
Minimal evidenceCerebrolysin
Neuropeptide preparation
Clinical-stageChonluten
Peptide bioregulator (Khavinson)
Minimal evidenceCJC-1295 + Ipamorelin
Growth hormone peptide blend
PreclinicalCJC-1295 with DAC
Long-acting GHRH analog
Clinical-stageHalf-life ~5.8–8.1 days
CJC-1295 without DAC
GHRH analog
PreclinicalCortagen
Peptide bioregulator (Khavinson)
Minimal evidenceCrystagen
Peptide bioregulator (Khavinson)
Minimal evidenceDermorphin
Opioid peptide
PreclinicalDihexa
Nootropic peptide (angiotensin-derived)
PreclinicalDSIP
Sleep-related neuropeptide
Clinical-stageDulaglutide
GLP-1 receptor agonist
Approved medicineHalf-life ~5 days
Epitalon
Peptide bioregulator (Khavinson)
Minimal evidenceEPO (Erythropoietin)
Erythropoiesis-stimulating agent
Approved medicineHalf-life ~4–13 hours (intravenous)
Follistatin 344
Myostatin-inhibiting protein
PreclinicalFOXO4
Senolytic peptide
PreclinicalGDF-8 (Myostatin)
Myostatin
PreclinicalGHK-CU
Copper peptide
Clinical-stageGHRP-2
Growth hormone–releasing peptide
Clinical-stageGHRP-6
Growth hormone–releasing peptide
PreclinicalGlutathione
Antioxidant tripeptide
Clinical-stageGonadorelin
GnRH analog
Clinical-stageHCG
Gonadotropin hormone
Approved medicineHexarelin
Growth hormone secretagogue
Clinical-stageHGH 191AA (Somatropin)
Recombinant human growth hormone
Approved medicineHalf-life ~7–10 hours (subcutaneous)
HGH Fragment 176-191
Growth hormone fragment
PreclinicalHMG
Gonadotropin preparation
Approved medicineHumanin
Mitochondrial-derived peptide
PreclinicalHyaluronic acid
Glycosaminoglycan
IGF-1 LR3
IGF-1 analog
PreclinicalIGF-DES
IGF-1 analog
PreclinicalInsulin
Peptide hormone
Approved medicineHalf-life ~1.5 hours (subcutaneous, regular human insulin)
Ipamorelin
Growth hormone secretagogue (ghrelin receptor agonist)
PreclinicalHalf-life ~2 hours
Ipamorelin + Tesamorelin
Growth hormone peptide blend
Minimal evidenceKissPeptin-10
Reproductive neuropeptide fragment
Clinical-stageKPV (Lysine–Proline–Valine)
Tripeptide fragment
PreclinicalL-Carnitine
Amino acid derivative
Approved medicineLemon Bottle
Fat-dissolving injectable (lipolysis)
Minimal evidenceLipo-C with B vitamins
Lipotropic injectable
Minimal evidenceLipo-C without B vitamins
Lipotropic injectable
Minimal evidenceLiraglutide
GLP-1 receptor agonist
Approved medicineHalf-life ~13 hours
Livagen
Peptide bioregulator (Khavinson)
Minimal evidenceLL37
Antimicrobial peptide (cathelicidin)
PreclinicalMatrixyl
Cosmetic peptide
Minimal evidenceMazdutide
GLP-1/glucagon dual receptor agonist
Clinical-stageMelatonin
Hormone (pineal)
Clinical-stageMGF (Mechano Growth Factor)
IGF-1 splice variant
PreclinicalMK-677 (Ibutamoren)
Growth hormone secretagogue
Clinical-stageMOTS-c
Mitochondrial-derived peptide
Clinical-stageMT-I
Melanocortin-1 receptor agonist
Approved medicineHalf-life ~15 hours (controlled-release implant)
MT-II
Melanocortin receptor agonist
Clinical-stageNAD+
Cellular cofactor
PreclinicalOligopeptide-10
Cosmetic antimicrobial peptide
Minimal evidenceOrexin A
Neuropeptide (hypocretin-1)
PreclinicalOrexin B
Neuropeptide (hypocretin-2)
PreclinicalOxytocin
Peptide hormone
Approved medicineHalf-life ~1–6 minutes
P21
Neurogenic peptide
PreclinicalPancragen
Peptide bioregulator (Khavinson)
Minimal evidencePE-22-28
Spadin analog (neuro)
PreclinicalPEG-MGF
IGF-1 splice variant analog
PreclinicalPinealon
Peptide bioregulator (Khavinson)
Minimal evidencePNC-27
Experimental anticancer peptide
PreclinicalProstamax
Peptide bioregulator (Khavinson)
Minimal evidencePT-141
Melanocortin receptor agonist
Approved medicineHalf-life ~2.7 hours
Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist
Clinical-stageHalf-life ~6 days
Selank
Anxiolytic peptide (tuftsin analog)
Minimal evidenceSemaglutide
GLP-1 receptor agonist
Approved medicineHalf-life ~1 week
Semax
Nootropic peptide (ACTH fragment)
Minimal evidenceSemax + Selank
Nootropic peptide blend
Minimal evidenceSermorelin Acetate
GHRH analog
Clinical-stageHalf-life ~10–20 minutes
SLU-PP-322
Small-molecule metabolic agonist
PreclinicalSnap-8
Cosmetic peptide
Minimal evidenceSS-31
Mitochondria-targeted peptide
Approved medicineSurvodutide
GLP-1/glucagon dual receptor agonist
Clinical-stageTB-500 (Thymosin Beta-4 fragment)
Thymosin beta-4 fragment
PreclinicalTeriparatide
PTH analog
Approved medicineHalf-life ~1 hour (subcutaneous)
Tesamorelin
GHRH analog
Approved medicineHalf-life ~11 minutes (subcutaneous)
Testagen
Peptide bioregulator (Khavinson)
Minimal evidenceThymalin
Thymic peptide extract
Minimal evidenceThymosin Alpha-1
Immunomodulating thymic peptide
Clinical-stageHalf-life ~2 hours
Tirzepatide
Dual GIP/GLP-1 receptor agonist
Approved medicineHalf-life ~5 days
Triptorelin Acetate
GnRH agonist
Approved medicineVilon
Peptide bioregulator (Khavinson)
Minimal evidenceVIP (Vasoactive Intestinal Peptide)
Neuropeptide vasodilator
Clinical-stageVitamin B12
Vitamin
Approved medicine